 Subjects will have had no infectious illnesses for one month prior to infusion. Should a subject develop an infection i.e. flu, upper respiratory viral infection between screening and infusion, the infusion will be delayed until 4 weeks after resolution of symptoms. As noted above, patients with a chronic infectious condition or with a past history of serious infectious complications will be excluded. 